📌 REGN pipeline (with particular focus on the early stages) CEMIPLIMAB, REGN3767, REGN1979, REGN4018, REGN5458, REGN5459, REGN5678, REGN5093, REGN5713-5714-5715 and REGN-COV2 all have a lot of potential with particular focus around oncology.
As can be see with GILD, the covid positioning has already moved on a lot: we are ready to play chapter II and REGN is a name worth considering for those looking to add single stock opps to their portfolio.
Buyers are clearly exercising control here on the Monthly chart at $600. To the topside there is very little in-between here and $1,000 as the next big level.
Thanks as usual for keeping the feedback coming 👍 or 👎